The oxidative burst response of neutrophils to bacteria is crucial for effective host defence. It has been shown that inhalation anaesthetics interfere with neutrophil function and the object of this study was to characterize the mechanisms of interaction of volatile anaesthetics with the oxidative response of neutrophils. H 2 O 2 production by neutrophils after stimulation with the bacterial peptide, N-formyl-L-methionyl-L-leucyl-phenylalanine (FMLP) and phorbol-12-myristate-13-acetate (PMA) was measured by oxidation of the indicator dye dihydrorhodamine using flow cytometry. FMLP binds to a specific surface receptor on neutrophils and initiates via receptor specific signal transduction respiratory burst as an all-ornone event, whereas PMA is an artificial activator of protein kinase C, which bypasses receptormediated signal transduction. In the presence of halothane, enflurane and sevoflurane, there was an increase in activation threshold on FMLP stimulation. Overall, this correlated with reduced H 2 O 2 production. Isoflurane had no effect. In the presence of desflurane, however, H 2 O 2 production of neutrophils increased two-fold, followed by transient suppression of neutrophil function. PMAinduced H 2 O 2 generation was unchanged in the presence of volatile anaesthetics. We conclude that volatile anaesthetics modulated FMLP receptordependent signal transduction upstream of protein kinase C activation, leading to a reduced response in the presence of halothane, enflurane and sevoflurane and to an increased response in the presence of desflurane. (Br.
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Neutrophil granulocytes are a major component of the non-antigen-specific, cell-mediated immune system. Activated by chemotactic signals, neutrophils migrate towards infected tissue ingesting and killing bacteria. A crucial mechanism of bacterial killing by neutrophils is generation of reactive oxygen derivatives. Because of the high oxygen uptake during generation of reactive oxygen species, this reaction has also been called respiratory burst. 1 The defence mechanism of oxygen radical production may be impaired, for example after drug exposure or during disease. Numerous studies have shown suppression of neutrophil oxidative function with halothane [2] [3] [4] [5] [6] and enflurane. [5] [6] [7] Isoflurane appears to have no, or only a minimal effect on neutrophils. 3-5 7 We have investigated the effects of several halogenated, volatile anaesthetics on the production of reactive oxygen derivatives in human neutrophils. Two different stimuli, N-formyl-methionyl-leucylphenylalanine and phorbol-13-myristate-12-acetate, were used to trigger respiratory burst in order to discriminate between receptor-dependent and independent mechanisms, respectively.
The flow cytometric assay used in this study allows quantification of the heterogenous oxidative response of neutrophils at the single cell level with low degrees of stimulation.
Materials and methods
The volatile anaesthetics used were obtained from the following companies: halothane from Hoechst, Germany; enflurane, sevoflurane and isoflurane from Abbott, Germany; desflurane from Pharmacia, Sweden. Carboxy -seminaphthorhodafluor -1 -acetoxymethylester (SNARF1/AM) and dihydrorho- ) whole blood (3 ml) was layered on top of 3 ml of lymphocyte separation medium (density 1.077 g ml
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) from Sigma Chemicals, Deisenhofen, Germany. Erythrocytes aggregated at the interface and settled at room temperature without centrifugation. After 40 min the upper 800 l of supernatant leucocyte-rich plasma were withdrawn, avoiding contact with the plasma fraction close to the interface with the separation medium. To avoid artificial activation of cells, the isolation process did not involve lysis, centrifugation or washing procedures.
RESPIRATORY BURST ASSAY
Each volatile anaesthetic was tested separately in vitro with neutrophils from the nine donors at four different concentrations (0, 0.5, 1.0, 2.0 MAC). The MAC values used for this study were: 0.8% for halothane, 1.7% for enflurane, 2% for sevoflurane, 1.2% for isoflurane and 6% for desflurane. 8 9 All anaesthetics were administered as volatile anaesthetic/air mixtures. The respiratory burst assay was performed in a 75 L airtight glovebox. Fresh gas was prepared using a gas mixing unit with calibrated vaporizers (Draeger, Lübeck, Germany). Fresh gas flow, after equilibration of the atmosphere inside the box with high flow rates, was 5 litre min 91 during the experiments. Inside the glovebox, samples were kept at 37ЊC with a heated aluminium block. To maintain the amount of evaporated water from the samples low, tubes were sealed with gas-permeable parafilm during all incubations. Volatile delivery under the hood was monitored continuously at the site of the sample tubes by a multi-gas analyser (Capnomac Ultima, Datex, Sweden).
Before filling the polypropylene tubes (diameter 10 mm) and adding leucocytes, Dulbecco's PBS was equilibrated with the anaesthetic inside the glovebox by bubbling fresh gas through for 30 min at 37ЊC. The leucocyte-rich plasma was suspended 1:50 (20 l of leucocytes and 980 l of PBS) in preequilibrated Dulbecco's PBS and incubated for 20 min at 37ЊC. The leucocytes were loaded with the fluorogenic substrates DHR and SNARF1/AM for 10 min. Cells were pre-exposed to the volatile anaesthetics for 30 min. The final concentrations were 1 mol litre 91 for DHR and 0.2 mol litre 91 for SNARF1/AM. Thereafter, FMLP or PMA (10 l) at a final concentration of 100 nmol litre 91 were added to initiate H 2 O 2 generation. After 15 min of incubation at 37ЊC the reaction was stopped on ice. Dead cells were counterstained with PI (10 l) at a final concentration of 30 mol litre
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. Samples were stored on ice in the dark and measured within 1 h. For evaluation of recovery of neutrophil function, the assay was repeated sequentially for both unexposed control and exposed samples: during exposure and 0.5 h, 1 h and 2 h after the end of exposure.
For analysis we used a FACScan flow cytometer (Becton Dickinson, San José, CA, USA) with argonion laser excitation at 488 nm, measuring 10 4 cells of each stained sample. Data were acquired and processed using LYSIS-II software provided by the cytometer manufacturer. In order to obtain absolute calibration of the fluorescence measurements the arbitrary fluorescence units of the cytometer were transformed into molecule equivalent of soluble fluorochrome (MESF) units. Therefore, after each experiment five populations of standard beads (Quantum 26) with a known content of fluorochrome were measured and a linear regression line was calculated. The MESF units were used for absolute quantification of cellular fluorescence, allowing inter-assay and inter-laboratory comparison of data. Dead cells were assessed by their PI fluorescence (above 600 nm). Leucocyte esterase activity, characteristic for viable cells, was determined based on SNARF1-related orange fluorescence. SNARF1/ AM is cleaved in vital leucocytes by esterases to fluorescent SNARF1. Neutrophils were identified by their typical side scatter light (SSC) and forward scatter light (FSC) patterns. SSC depends on the granularity of cells, whereas FSC is related to the size of cells.
GAS CHROMATOGRAPHY/MASS SPECTROMETRY
For assessment of the concentrations of volatile anaesthetics in the fluid phase of our experiments, we used gas chromatography/high resolution mass spectrometry (GC/HRMS) with a HRGC Mega 2 series (Fisons Instruments SpA, Rodano, Italy). Elution was performed on a 20 m 0.27 mm glass capillary column coated with a 2.1-m film of PS 090 (Petrarch Systems Inc., Bristol, PA 19007, USA). The carrier gas was hydrogen at a head pressure of 30 kPa (linear flow rate 0.3 m s
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). Samples of 0.75 l were injected into the split injector (temperature 250ЊC, split ratio 1:20); oven temperature was kept at an ambient temperature of 24ЊC. The mass spectrometer MAT 95 (Finnigan MAT, Bremen, Germany) was run in electron impact mode at 70 eV electron energy (ion source temperature 180ЊC). The mass resolution m/⌬m was set to 7500; the multiplier voltage was 1.4 kV. Typical ions were recorded by single ion monitoring (SIM) using perfluorotributylamine and carbon dioxide, respectively, as references; cycle time was 0.2 s. Quantification was based on signal areas in the mass chromatograms.
STATISTICAL ANALYSIS
All data are presented as mean (SD) and range. Analysis of variance and the Student-NewmanKeuls test for multiple pairwise comparison at a significance level of P:0.05 were used to compare controls and drug-exposed samples. MAC was designated as the independent variable for analysis of variance to evaluate the effects of different concentrations of volatile anaesthetics. To test the significance of differences in the recovery kinetic data, the Student's t test was used. We compared mean fluorescence of unexposed controls processed in parallel with volatile anaesthetic-exposed aliquots. Figure 1A shows flow cytometric analysis of resting, non-stimulated leucocytes, whereas figure 1B displays the heterogenous reaction of neutrophils on FMLP stimulation. In contrast, the PMA-induced reaction of all cells was homogenous ( fig. 1C) . The percentage of reacting and non-reacting neutrophils is given on the left of each dot plot. The percentage of dead cells was lower than 0.1% independent of drug exposure or stimulation.
Results
In the presence of halothane the reactive oxygen derivative generation of neutrophils and monocytes was significantly reduced. At 1 MAC mean fluorescence was 50% compared with control ( fig. 1D) In contrast with all other anaesthetics, the oxidative response after stimulation was enhanced in the presence of desflurane. Both mean fluorescence and percentage of neutrophils responding with a respiratory burst reaction were increased compared with controls ( fig. 1E, tables 1, 2) . Recovery data are given as the ratio between fluorescence of the exposed and non-exposed samples (table 3). Significant differences between control and drug exposed samples were found for halothane up to 30 min after exposure. Desflurane exposed neutrophils showed transient depression of respiratory burst activity on FMLP stimulation. The impairment lasted less than 2 h.
By GC/HRMS the following buffer/gas partition coefficients and concentrations of volatile anaesthetics for 37ЊC and 1 MAC were confirmed: halothane 0.663 and 0.24 (0.01) mmol litre . Equilibration was complete after 10 min for all anaesthetics. Ten minutes after removal of the anaesthetic, concentrations in the fluid phase decreased to less than 2% of the initial concentration. The relationship between fluid-and gas-phase concentration was linear in the range relevant to this study.
Discussion
In this in vitro study we have investigated the ability of human neutrophils to form reactive oxygen products after FMLP stimulation during and after exposure to volatile anaesthetics. Unlike other investigators we used MAC-related concentrations in order to compare equipotent concentrations of anaesthetics. The measured buffer/gas partition coefficients were lower than those coefficients given for blood by other authors and met the coefficients published for saline. [10] [11] [12] This may lead to underestimation of the effects presented in this report. In terms of molarity, the MAC-derived differences in concentration were smaller in the fluid phase than in the gas phase of the experiment. For example, 1 MAC of halothane (0.8 vol%) corresponded to 0.24 mmol litre
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, whereas 1 MAC of desflurane (6.0 vol%) was only 0.63 mmol litre
. The small amounts of intracellular H 2 O 2 generated after stimulation were assessed by quantifying the intracellular oxidation of the indicator dye dihydrorhodamine-123 to rhodamine-123. 13 The former is a non-fluorescent and membranepermeable fluorogenic substrate whereas the latter oxidation product emits green light (510-530 nm) on excitation.
14 This method has several advantages over those used previously for quantifying neutrophil oxidative function. First, purification of neutrophils, which often leads to artefactual activation of cells, is unnecessary. Second, flow cytometric results are not affected by variations in concentration of neutrophils in the assay, as each individual neutrophil is measured and not the average response of all those assayed. Thus we can show the heterogenous response of neutrophils in an all-or-none reaction after stimulation; only a subset of all neutrophils respond with the respiratory burst reaction on FMLP stimulation while the others remain resting (fig. 1B) .
In our study, halothane and enflurane caused a reversible decrease in the formation of H 2 O 2 , which is in accordance with the results of other investigators. [2] [3] [4] [5] [6] [7] This inhibition was characterized by a decrease in production of respiratory burst products per neutrophil, and reduction in the number of neutrophils recruited for respiratory burst. Desflurane enhanced the neutrophil response significantly, and a transient decrease in neutrophil oxidative burst activity ensued after removal of anaesthetic. The increased activity not only correlated with increased recruitment of neutrophils, but also enhanced intracellular H 2 O 2 per cell. Enhanced neutrophil function in the presence of isoflurane has also been shown by Erskine and James 4 and by Nakagawara and colleagues 5 for a concentration corresponding to 2 MAC. The reported effects of isoflurane were not significant in our experiments. Using the receptor independent stimulus PMA, none of the anaesthetics at any concentration had an effect on the oxidative response. The finding of unchanged PMA-induced respiratory burst in the presence of all volatile anaesthetics excludes two potential causes of altered H 2 O 2 production: scavenging of reactive oxygen derivatives by volatile anaesthetics and direct interference with H 2 O 2 generating enzymes. Furthermore, Nakagawara and colleagues 5 tested the ability of halothane to scavenge respiratory burst products in celldependent and cell-free systems. Neither halothane nor enflurane were able to reduce the amount of generated reactive oxygen products. Thus the significant decrease in H 2 O 2 production of monocytes in the presence of halothane ( fig. 1D ) was most likely caused by interference with regulation of the spontaneous oxidative burst of monocytes. This regulation involves signalling pathways different from those mediating neutrophil respiratory burst.
Halothane, enflurane and sevoflurane increased and desflurane decreased the threshold for FMLPdependent activation such that the number of neutrophils displaying respiratory burst on stimulation declined or increased. PMA activates respiratory burst through the same signal transduction chain as FMLP but at a later activation step. Nakagawara and colleagues 5 investigated the affinity of the FMLP receptor for its agonist in the presence of volatile anaesthetics by measuring the uptake of radioactive labelled FMLP. They found an unchanged affinity of the receptor in the presence of halothane and enflurane. Thus halothane, enflurane and sevoflurane appear to interfere with intracellular signal transduction downstream of the FMLP receptor and upstream of the activation site of PMA.
The bacterial peptide FMLP is a physiological agonist for specific receptors on neutrophils. FMLP has been shown to be a major chemotaxin for neutrophils, and phagocytosis of Escherichia coli is mediated mainly by FMLP and its receptor on the neutrophil surface. 15 The concentration of 100 nmol litre 91 for FMLP was chosen to allow analysis of the heterogenous response of neutrophils. This concentration also allows comparison with results of other authors. 5 FMLP triggers multiple responses, including chemotaxis, exocytosis of certain enzymes and superoxide generation by the NADPH oxidase complex, the so-called respiratory burst. 1 16-18 Binding of FMLP to the G-protein-coupled receptor induces a temporary increase in phosphatidylinositol-1,4,5-triphosphate, cytosolic calcium, 1,2 diacylglycerol (DAG) and other activators of protein kinase C (PKC). 19 20 Human neutrophils express four PKC isoenzymes (␣, ␤I, ␤II, ) PKC␤ and are the most abundant isoforms, while PKC␣ is hardly detectable. After stimulation with FMLP the PKC isoforms ␤I, ␤II and are redistributed from the cytosol to the plasma membrane. PMA is a synthetic analogue of DAG and therefore induces a similar redistribution and activation of PKC, but unlike FMLP the redistribution of PKC is irreversible. 21 The membrane bound form of PKC activates, by intermediate steps, NADPH oxidase. By a single electron transfer, this oxidase transforms molecular oxygen into superoxide anion. Superoxide then dismutates to hydrogen peroxide (H 2 O 2 ) inside the phagosomes or in the extracellular space. 1 17 Activation of respiratory burst depends on calmodulin, 22 23 as deduced from experiments using specific antagonists. Calmodulin, an ubiquitous lowmolecular-weight protein, regulates the calciumdependent activity of various enzymes. Périanin, Pedruzzi and Hakim 22 demonstrated that the calmodulin antagonist W-7 dose-dependently enhances and depresses the respiratory burst reaction. Levin and Blanck 24 showed that halothane and isoflurane interfered with the affinity of calmodulin for calcium. Low concentrations of halothane (0.57%) decreased the affinity, whereas higher concentrations (5.7%) significantly increased the ability to bind calcium. The latter effect was found to be irreversible. 24 Isoflurane behaved in a similar way, but halothane was more potent when compared on the basis of MAC values.
These findings may explain the ability of desflurane to enhance and of halothane, enflurane and sevoflurane to lower respiratory burst by interfering with calmodulin, in a manner similar to the known calmodulin antagonist W-7. 22 Thus desflurane might interfere in the same manner as high-dose isoflurane in the experiments of Levin and Blanck, 24 increase the ability of calmodulin to bind calcium and subsequently enhance respiratory burst. This interaction should be irreversible, so that temporary depression of neutrophil function after desflurane exposure might depend on protein synthesis leading to restoration of calmodulin with a normal affinity for calcium. In contrast, halothane or enflurane might decrease the ability of calmodulin to bind calcium and should therefore lead to an immediately reversible inhibition of respiratory burst.
The clinical relevance of impairment of neutrophil function cannot be deduced as our experimental design was not suitable for quantifying clinical effects.
